These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3162898)

  • 1. Susceptibility of Pseudomonas pseudomallei to new beta-lactam and aminoglycoside antibiotics.
    McEniry DW; Gillespie SH; Felmingham D
    J Antimicrob Chemother; 1988 Feb; 21(2):171-5. PubMed ID: 3162898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-formimidoyl-thienamycin and norfloxacin against multiple-resistant Pseudomonas aeruginosa strains. Combined in vitro activity and comparison with 14 other antibiotics.
    Martino P; Venditti M; Valente B; Brandimarte C; Serra P
    Drugs Exp Clin Res; 1985; 11(4):247-51. PubMed ID: 3939121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative antimicrobial activity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp.
    Baltch AL; Smith RP; Ritz W
    Chemotherapy; 1994; 40(6):391-8. PubMed ID: 7842822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro susceptibility of Pseudomonas aeruginosa to old and new beta-lactam antibiotics and aminoglycosides.
    Van der Auwera P; Schuyteneer F
    J Antimicrob Chemother; 1983 Jun; 11(6):511-5. PubMed ID: 6411673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro susceptibility of clinical isolates of Pseudomonas aeruginosa to beta-lactam and aminoglycoside antibiotics.
    Sofianou DC; Vrenas S; Doumboyas J
    J Chemother; 1989 Dec; 1(6):391-3. PubMed ID: 2515260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-lactamase induction and aminoglycoside susceptibility in Pseudomonas aeruginosa.
    Stratton CW; Weeks LS; Tausk F
    J Antimicrob Chemother; 1987 Jan; 19(1):21-5. PubMed ID: 3104276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas pseudomallei, a common pathogen in Thailand that is resistant to the bactericidal effects of many antibiotics.
    Sookpranee T; Sookpranee M; Mellencamp MA; Preheim LC
    Antimicrob Agents Chemother; 1991 Mar; 35(3):484-9. PubMed ID: 2039198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment.
    Dance DA; Wuthiekanun V; Chaowagul W; White NJ
    J Antimicrob Chemother; 1989 Sep; 24(3):295-309. PubMed ID: 2681116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of imipenem and six other beta-lactam antibiotics against aminoglycoside resistant gram-negative bacilli.
    Bujdáková H; Kallová J; Lausová A; Kettner M
    Microbios; 1995; 84(339):87-90. PubMed ID: 8628124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antibacterial activity of imipenem against Pseudomonas and Staphylococcus species. Comparison with thirteen other antimicrobial agents.
    Cristiano P; Abbate GF; Alagia I; Leonessa V; Giaquinto E; Savioli L
    Drugs Exp Clin Res; 1985; 11(1):39-48. PubMed ID: 3869802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of imipenem--a review.
    Braveny I
    Eur J Clin Microbiol; 1984 Oct; 3(5):456-62. PubMed ID: 6389125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collateral sensitivity between aminoglycosides and beta-lactam antibiotics depends on active proton pumps.
    Azimi L; Rastegar Lari A
    Microb Pathog; 2017 Nov; 112():122-125. PubMed ID: 28958949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimicrobial susceptibility of Pseudomonas aeruginosa isolated at Kochi Municipal Central Hospital in the last 3 years].
    Nasu Y; Abe M; Ono N; Araki M; Horimi T; Takahashi I
    Jpn J Antibiot; 2004 Oct; 57(5):438-48. PubMed ID: 15655905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ro 17-2301: in vitro comparison with aztreonam, imipenem, ceftazidime, cefotaxime and netilmicin.
    Digranes A; Dibb WL; Benonisen E; Salveson A
    Chemotherapy; 1985; 31(4):279-85. PubMed ID: 3928281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of carumonam (RO 17-2301) and twelve other antimicrobials against clinical isolates of Pseudomonas aeruginosa.
    Vurma-Rapp U; Kayser FH
    Eur J Clin Microbiol; 1986 Jun; 5(3):292-6. PubMed ID: 3091365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility pattern of clinical isolates of Burkholderia pseudomallei in Bangladesh.
    Dutta S; Haq S; Hasan MR; Haq JA
    BMC Res Notes; 2017 Jul; 10(1):299. PubMed ID: 28728591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Pseudomonas aeruginosa alginate expression by subinhibitory concentrations of antibiotics.
    Majtán V; Hybenová D
    Folia Microbiol (Praha); 1996; 41(1):61-4. PubMed ID: 9090826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro sensitivity at 18 antibiotics of 192 strains of Pseudomonas aeruginosa isolated at Garches Hospital].
    Ronco E; Vacheron F; Orabona A
    Pathol Biol (Paris); 1987 May; 35(5):558-62. PubMed ID: 3112708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Susceptibility of Global Surveillance Isolates of Pseudomonas aeruginosa to Ceftazidime-Avibactam (INFORM 2012 to 2014).
    Nichols WW; de Jonge BL; Kazmierczak KM; Karlowsky JA; Sahm DF
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4743-9. PubMed ID: 27216074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.